1. Biogen Data on file. 2. Polman, C. et al. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. New England Journal of Medicine 354, 899-910 (2006). 3. Butzkueven, H. et al. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. Journa of Neurology, Neurosurgery & Psychiatry 85, 1190-1197 (2014).